- Home
- Healthcare professionals
- ACE Technology Guidances
- Medical Technology Guidances
- Lumbar artificial disc replacement for treatment of patients with lumbar disc degenerative disease
Lumbar artificial disc replacement for treatment of patients with lumbar disc degenerative disease
1 May 2024
Published on 01 May 2024
Last Updated on 01 May 2024
Guidance Recommendations
The Ministry of Health’s Medical Technology Advisory Committee has recommended lumbar artificial disc replacement (L-ADR) for the treatment of symptomatic lumbar disc degenerative disease (DDD) in line with the following criteria:
Skeletally mature patients with symptomatic single level or two contiguous levels of lumbar DDD and low back pain (with or without neurologic deficit), confirmed by clinical examination and medical imaging, who:
require reconstruction of the lumbar spinal disc; and
have failed to respond to conservative medical management.
Funding status
L-ADR is recommended for inclusion on the MOH Implant Subsidy List (ISL). Listed models are recommended for subsidy when used in line with the abovementioned recommendation.